A cheeky website about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. If you have a tip, want to discuss a story or have a subscription enquiry please feel free to email Betaville at [email protected]. Betaville can also be reached at Whats App, Signal or Telegram. Betaville's Twitter handle is @bharringtonw11 and you can message me via Twitter with stories.

HSBC takeaway - part 2

Friday, 5 February 2016, 1:20 am

Readers might recall that earlier this week HSBC was quick out of the blocks to boast how it was the "sole" financial advisor to ChemChina on its $43 billion purchase of Sygenta, sending out a release on topic in the early hours of Wednesday morning...

Read more...

HSBC takeaway

Wednesday, 3 February 2016, 9:33 am

Ping! An email arrives from HSBC with the headline:

HSBC sole financial advisor to ChemChina on Syngenta acquisition

That's before I had even received the formal $43 billion deal announcement from Syngenta or ChemChina...

Read more...

Burmese Business - part 4

Friday, 29 January 2016, 1:53 am

It still never ceases to amaze me how quickly stocks fall in and out of fashion with investors, traders and market participants.

Indeed, the healthcare/ biotech sector has taken another serious pasting today following worse-than-expected figures from Roche, the Swiss pharmaceutical giant. So, AstraZeneca is down 3pc today while Shire has fallen almost 5pc.

However, there is one stock that has quiet literally reversed a rout of its share price: MySQUAR...

Read more...

Irritating

Thursday, 28 January 2016, 10:08 pm

If there is one thing that really irritates me it's being beaten to the punch by rival hacks on a story I had spent several days trying to stand up.

Yes, that does occasionally happen to me.

And yesterday was particularly galling as I was just about publish a piece about how the Novum takeover had run into difficulties when hacks and hackettes at the Financial Times released their version of the jackanory. Here is a link to their piece:..

Read more...

Shell/BG Group worries - part 5

Thursday, 28 January 2016, 4:39 am

I see Royal Dutch Shell's £35 billion purchase of BG Group has been approved by over 80pc of the  Anglo Dutch company's shareholders.

So I guess the Telegraph's recent scaremongering about the deal collapsing, led by Jupiter fund manager Ian McVeigh, was just, err, scaremongering......

Read more...

Top of the market? - part 5

Tuesday, 26 January 2016, 6:33 pm

Stockmarkets around the world are taking another hammering this week, with the FTSE 100 down  1pc this morning after a major sell off in China.

So, I'm wondering whether the "top of the market" series I started on little old Betaville last summer highlighting several clear "top-of-the-market" indicators was a rather prescient warning for investors?

Or, perhaps this is just a "correction" ahead of another leg up post a few interest rate rises in US?..

Read more...

Sunday review

Monday, 25 January 2016, 3:53 am

There were plenty of interesting stories in the Sunday newspaper business sections this weekend.

One tale, though, that caught my eye was the business splash of The Sunday Times.

Oliver Shah and Peter Evans, biz hacks over at The Sunday Times, discovered that giant US hedge fund Och-Ziff has been secretly building a stake in GlaxoSmithKline, Britain's biggest pharma company, and is now putting pressure on the FTSE 100 company's board...

Read more...

Lipin in the limelight

Friday, 22 January 2016, 11:37 pm

I'm not in the habit of giving Bloomberg much praise as the journalists that work there are pretty good at praising themselves...

Read more...

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].